ICD-10 Coding for Transaminitis Secondary to Rosuvastatin(T46.6X5A, K71.9, R74.01)
Complete ICD-10-CM coding and documentation guide for Transaminitis Secondary to Rosuvastatin. Includes clinical validation requirements, documentation requirements, and coding pitfalls.
Also known as:
Related ICD-10 Code Ranges
Complete code families applicable to Transaminitis Secondary to Rosuvastatin
T36-T50Primary Range
Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances
This range includes codes for adverse effects of drugs, including statins like rosuvastatin.
Diseases of liver
This range includes codes for liver diseases, including toxic liver disease and elevated liver enzymes.
Code Comparison: When to Use Each Code
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| T46.6X5A | Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter | Use when there is a documented adverse effect of rosuvastatin causing liver enzyme elevation. |
|
| K71.9 | Toxic liver disease, unspecified | Use when there is confirmed drug-induced liver injury without specific etiology. |
|
| R74.01 | Elevation of levels of liver transaminases and lactic acid dehydrogenase [LDH] | Use when there is an elevation of liver enzymes without a specific diagnosis of liver disease. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information: ICD-10 code for transaminitis due to rosuvastatin
Essential facts and insights about Transaminitis Secondary to Rosuvastatin
Primary ICD-10-CM Codes for transaminitis secondary to rosuvastatin
Decision Criteria
clinical Criteria
- Presence of elevated liver enzymes temporally related to rosuvastatin use.
documentation Criteria
- Explicit mention of rosuvastatin as the cause of liver enzyme elevation.
Applicable To
- Adverse effect of rosuvastatin
Excludes
- Poisoning by antihyperlipidemic drugs (T46.6X1-)
Clinical Validation Requirements
- Documented adverse reaction to rosuvastatin
- Temporal relationship between drug administration and symptom onset
Code-Specific Risks
- Failure to document the drug as the cause can lead to incorrect coding.
Coding Notes
- Always pair T46.6X5A with a code for the specific liver condition caused by the drug.
K71.9 - Toxic liver disease, unspecified
Use when there is confirmed drug-induced liver injury without specific etiology.
Applicable To
- Drug-induced liver injury
Excludes
- Alcoholic liver disease (K70.-)
Clinical Validation Requirements
- Exclusion of viral and autoimmune hepatitis
- Liver biopsy or imaging confirming hepatocellular injury
Coding Notes
Ensure documentation excludes other causes of liver disease.
R74.01 - Elevation of levels of liver transaminases and lactic acid dehydrogenase [LDH]
Use when there is an elevation of liver enzymes without a specific diagnosis of liver disease.
Applicable To
- Elevated liver enzymes
Excludes
- Liver disease with elevated enzymes (K70-K77)
Clinical Validation Requirements
- Documented lab results showing elevated ALT/AST levels
Coding Notes
Ensure enzyme elevation is linked to drug use in documentation.
Ancillary Codes
Additional codes that should be used in conjunction with the main diagnosis codes when applicable.
Differential Codes
Alternative codes to consider when ruling out similar conditions to the primary diagnosis.
Documentation & Coding Risks
Avoid these common documentation and coding issues when documenting Transaminitis Secondary to Rosuvastatin to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code T46.6X5A.
Impact
Clinical: May lead to misdiagnosis and inappropriate treatment., Regulatory: Non-compliance with coding standards., Financial: Potential for denied claims or reduced reimbursement.
Mitigation Strategy
Ensure documentation explicitly states drug as cause., Use templates to guide documentation.
Impact
Reimbursement: May lead to lower reimbursement due to incomplete coding., Compliance: Non-compliance with ICD-10 coding guidelines., Data Quality: Inaccurate representation of the patient's condition.
Mitigation Strategy
Always pair R74.01 with T46.6X5A for adverse drug reactions.
Impact
Reimbursement: Incorrect coding may affect DRG assignment., Compliance: Misrepresentation of the patient's condition., Data Quality: Inaccurate clinical data for research and analysis.
Mitigation Strategy
Use T46.6X5A for adverse effects, not Z91.14 for intolerance.
Impact
Failure to use both adverse effect and liver condition codes.
Mitigation Strategy
Implement coding audits and education on proper code combinations.
Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.
Frequently Asked Questions
Common questions about ICD-10 coding for Transaminitis Secondary to Rosuvastatin, with expert answers to help guide accurate code selection and documentation.
Documentation Templates for Transaminitis Secondary to Rosuvastatin
Use these documentation templates to ensure complete and accurate documentation for Transaminitis Secondary to Rosuvastatin. These templates include all required elements for proper coding and billing.
Patient with elevated liver enzymes due to rosuvastatin
Specialty: GastroenterologyRequired Elements
- Patient history of rosuvastatin use
- Lab results showing elevated ALT/AST
- Exclusion of other liver disease causes
- Plan for discontinuation of rosuvastatin
Example Documentation
Examples: Poor vs. Good Documentation
Poor Documentation Example
Good Documentation Example
Explanation
Need help with ICD-10 coding for Transaminitis Secondary to Rosuvastatin? Ask your questions below.